(Q43734561)

26 November 2017

title

Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn (English)

1 reference

26 November 2017

1 reference

Robinson M

1

1 reference

26 November 2017

Rodriguez-Stanley S

2

1 reference

26 November 2017

Ciociola AA

3

1 reference

26 November 2017

Filinto J

4

1 reference

26 November 2017

Zubaidi S

5

1 reference

26 November 2017

Miner PB Jr

6

1 reference

26 November 2017

Gardner JD

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Alimentary Pharmacology & Therapeutics

26 November 2017

published in

1 reference

26 November 2017

volume

15

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

1365-1374

1 reference

Failure of transient lower oesophageal sphincter relaxation in response to gastric distension in patients with achalasia: evidence for neural mediation of transient lower oesophageal sphincter relaxations

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Low-dose ranitidine for the relief of heartburn

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Concentration of refluxed acid and esophageal mucosal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Comparison of low-dose antacids, cimetidine, and placebo on 24-hour intragastric acidity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Food but not a chemically defined diet interferes with maintenance of intragastric pH at a predefined level using continuous pH-stat-adjusted intravenous infusion of ranitidine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

In Vivo and in Vitro Evaluation of Liquid Antacids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

In vivo and in vitro evaluation of magnesium-aluminum hydroxide antacid tablets and liquid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus"

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01058.X

10.1046/J.1365-2036.2001.01058.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference